155 related articles for article (PubMed ID: 16802495)
1. Use of recombinant activated factor VII after axillofemoral bypass grafting.
Cheng CA; Ho AM
Anaesth Intensive Care; 2006 Jun; 34(3):375-8. PubMed ID: 16802495
[TBL] [Abstract][Full Text] [Related]
2. Effective management of refractory postcardiotomy bleeding with the use of recombinant activated factor VII.
Filsoufi F; Castillo JG; Rahmanian PB; Scurlock C; Fischer G; Adams DH
Ann Thorac Surg; 2006 Nov; 82(5):1779-83. PubMed ID: 17062247
[TBL] [Abstract][Full Text] [Related]
3. The use of recombinant coagulation factor VIIa in uncontrolled postoperative bleeding in children undergoing cardiac surgery with cardiopulmonary bypass.
Pychyńska-Pokorska M; Moll JJ; Krajewski W; Jarosik P
Pediatr Crit Care Med; 2004 May; 5(3):246-50. PubMed ID: 15115562
[TBL] [Abstract][Full Text] [Related]
4. Role of recombinant factor VIIa in the treatment of intractable bleeding in vascular surgery.
Končar IB; Davidović LB; Savić N; Sinđelić RB; Ilić N; Dragas M; Markovic M; Kostic D
J Vasc Surg; 2011 Apr; 53(4):1032-7. PubMed ID: 21215579
[TBL] [Abstract][Full Text] [Related]
5. Successful graft patency after factor VIIa use for bleeding in coronary artery surgery: an unusual complication of a coronary artery bypass surgery.
Wahed S; Karagounis AP; Niranjan G; Kanagasabay R
J Card Surg; 2007; 22(5):424-7. PubMed ID: 17803583
[TBL] [Abstract][Full Text] [Related]
6. Recombinant factor VIIa in the treatment of postoperative hemorrhage after cardiac surgery.
Raivio P; Suojaranta-Ylinen R; Kuitunen AH
Ann Thorac Surg; 2005 Jul; 80(1):66-71. PubMed ID: 15975342
[TBL] [Abstract][Full Text] [Related]
7. [Recombinant activated factor VII in the treatment of intractable non-surgical bleeding following major vascular procedures].
Koncar IB; Savić N; Davidović LB; Simić D; Marković D; Sindjelić R
Srp Arh Celok Lek; 2008; 136(7-8):367-72. PubMed ID: 18959171
[TBL] [Abstract][Full Text] [Related]
8. Pharmacologic therapy for postoperative bleeding in children after cardiac surgery: when will the bleeding stop?
Yan Q; Chang AC
Pediatr Crit Care Med; 2004 May; 5(3):297-8. PubMed ID: 15167716
[No Abstract] [Full Text] [Related]
9. Critical bleeding in vascular surgery: expanding the indication of recombinant activated factor VII.
Tawfick WA; Tawfik S; Hynes N; Mahendran B; Sultan S
Vascular; 2006; 14(1):32-7. PubMed ID: 16849021
[TBL] [Abstract][Full Text] [Related]
10. Recombinant activated factor VII for refractory bleeding after cardiac surgery--a retrospective analysis of safety and efficacy.
von Heymann C; Redlich U; Jain U; Kastrup M; Schroeder T; Sander M; Grosse J; Ziemer S; Koscielny J; Konertz WF; Wernecke KD; Spies C
Crit Care Med; 2005 Oct; 33(10):2241-6. PubMed ID: 16215377
[TBL] [Abstract][Full Text] [Related]
11. Experience with recombinant-activated factor VII in 30 patients with congenital factor VII deficiency.
Brenner B; Wiis J
Hematology; 2007 Feb; 12(1):55-62. PubMed ID: 17364994
[TBL] [Abstract][Full Text] [Related]
12. Recombinant factor VIIa use in cardiac surgery--expanding the arsenal therapy for intractable bleeding?
Kogan A; Berman M; Stein M; Vidne BA; Raanani E
J Cardiovasc Surg (Torino); 2004 Dec; 45(6):569-71. PubMed ID: 15746637
[TBL] [Abstract][Full Text] [Related]
13. Off-label use of recombinant factor VIIA concentrates after cardiac surgery.
Despotis G; Avidan M; Lublin DM
Ann Thorac Surg; 2005 Jul; 80(1):3-5. PubMed ID: 15975330
[No Abstract] [Full Text] [Related]
14. Audit of factor VIIa for bleeding resistant to conventional therapy following complex cardiac surgery.
McCall P; Story DA; Karalapillai D
Can J Anaesth; 2006 Sep; 53(9):926-33. PubMed ID: 16960271
[TBL] [Abstract][Full Text] [Related]
15. Recombinant activated factor VII for treatment of refractory hemorrhage after surgery for acute aortic dissection.
Grubitzsch H; Vargas-Hein O; Von Heymann C; Konertz W
J Cardiovasc Surg (Torino); 2009 Aug; 50(4):531-4. PubMed ID: 18948874
[TBL] [Abstract][Full Text] [Related]
16. Investigation of outcomes following recombinant activated FVII use for refractory bleeding during abdominal aortic aneurysm repair.
Kandane-Rathnayake RK; Willis CD; Beiles CB; Bourke BM; Cameron PA; McCall P; Phillips LE
Eur J Vasc Endovasc Surg; 2013 Jun; 45(6):617-25. PubMed ID: 23433950
[TBL] [Abstract][Full Text] [Related]
17. Use of recombinant factor VIIa as a rescue treatment for intractable bleeding following repeat aortic arch repair.
Stratmann G; Russell IA; Merrick SH
Ann Thorac Surg; 2003 Dec; 76(6):2094-7. PubMed ID: 14667657
[TBL] [Abstract][Full Text] [Related]
18. Predicting response to recombinant factor VIIa in non-haemophiliac patients with severe haemorrhage.
Bowles KM; Callaghan CJ; Taylor AL; Harris RJ; Pettigrew GJ; Baglin TP; Park GR
Br J Anaesth; 2006 Oct; 97(4):476-81. PubMed ID: 16914465
[TBL] [Abstract][Full Text] [Related]
19. Review of the off-label use of recombinant activated factor VII in pediatric cardiac surgery patients.
Guzzetta NA; Russell IA; Williams GD
Anesth Analg; 2012 Aug; 115(2):364-78. PubMed ID: 22652310
[TBL] [Abstract][Full Text] [Related]
20. [Recombinant activated factor VII for perioperative bleeding].
López R; Aeschlimann N; Carvajal C; Lema G
Rev Med Chil; 2009 Jun; 137(6):837-43. PubMed ID: 19746288
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
